Retinol Binding Protein-4 and Adiponectin Levels in Thyroid Overt and Subclinical Dysfunction

Abstract

Thyroid dysfunction is accompanied by numerous changes in intermediary metabolism. Retinol binding protein-4 (RBP-4) and adiponectin are 2 adipocytokines that have multiple metabolic functions. The aim of our study was to examine serum RBP4 and adiponectin levels in clinical (before and after therapy) and subclinical hyperthyroid and hypothyroid subjects as compared to controls.

150 patients with thyroid dysfunction were recruited (65 hyperthyroid and 85 hypothyroid) while 28 euthyroid subjects served as a control group. We measured anthropometric, biochemical and hormonal (free T4, free T3, TSH, insulin) parameters in all participants. RBP-4 and adiponectin were measured using commercial ELISA kits.

Mean baseline levels of RBP-4 were higher in patients with clinical hypothyroidism (29.0±10.2 ng/ml, 25.1±12.6 ng/ml, 38.8±16.5 ng/ml, 31.9±13.2 ng/ml, 20.4±8.2 ng/ml in patients with hyperthyroidism, subclinical hyperthryrodism, hypothyroidism, subclinical hypothyroidism and controls respectively, F=4.86, P<0.001) and decreased significantly in patients with clinical hyperthyroidism and hypothyroidism after normalization of thyroid hormones’ levels (from 29.0±10.2 to 24.9±8.4 ng/ml, p=0.003 and from 38.8±16.5 to 29.0±10.8 ng/ml, p=0.001 respectively). We did not observe analogous changes in adiponectin levels in any of the studied groups.

RBP-4 levels are higher in patients with clinical hypothyroidism and exhibit a marked decrease after normalization of thyroid function in both hyper and hypothyroid patients. We suggest that RBP-4 may play a role in the metabolic disturbances which accompany thyroid dysfunction.

Key words

retinol binding protein-4 (RBP-4) - adiponectin - hyperthyroidism - hypothyroidism - insulin resistance

• References

• 1 Wozniak SE, Gee LL, Wachtel MS et al. Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci 2009; 54: 1847-1856
• 2 Heimberg M, Olubadewo JO, Wilcox HG. Plasma lipoproteins and regulation of hepatic metabolism of fatty acids in altered thyroid states. Endocr Rev 1985; 6: 590-607
• 3 Maratou E, Hadjidakis DJ, Peppa M et al. Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism. Eur J Endocrinol 2010; 163: 625-630
• 4 Nikzas D, Tountas N, Economopoulos T et al. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol 2009; 160: 785-790
• 5 Tamori Y, Sakaue H, Kasuga M. RBP4 an unexpected adipokine. Nat Med 2006; 12: 30-31
• 6 Christou GA, Tselepis AD, Kiortsis DN. The metabolic role of retinol binding protein 4: an update. Horm Metab Res 2012; 44: 6-14
• 7 Esteve E, Ricart W, Fernandez-Real JM. Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin. Diabetes Care 2009; 32: S362-S367
• 8 Graham TE, Yang Q, Blüher M et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006; 354: 2552-2563
• 9 Arita Y, Kihara S, Ouchi N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79-83
• 10 Okamoto Y, Kihara S, Funahashi T et al. Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci (Lond) 2006; 110: 267-278
• 11 Trujillo ME, Scherer PE. Adiponectin – journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 2005; 257: 167-175
• 12 Choi SH, Lee YJ, Park YJ et al. Retinol binding protein-4 elevation is associated with serum thyroid-stimulating hormone level independently of obesity in elderly subjects with normal glucose tolerance. J Clin Endocrinol Metab 2008; 93: 2313-2318
• 13 Güdücü N, Görmüs U, Kavak ZN et al. Retinol-binding protein 4 is elevated and is associated with free testosterone and TSH in postmenopausal women. J Endocrinol Invest 2013; 36: 831-834
• 14 Peppa M, Koliaki C, Nikolopoulos P et al. Skeletal Muscle Insulin Resistance in Endocrine Disease. J Biomed Biotechnol 2010; 2010: 527850
• 15 Rochon C, Tauveron I, Dejax C et al. Response of glucose disposal to hyperinsulinaemia in human hypothyroidism and hyperthyroidism. Clin Sci (Lond) 2003; 104: 7-15
• 16 Gabriela B. Why Can Insulin Resistance Be a Natural Consequence of Thyroid Dysfunction?. J Thyroid Res 2011; 2011: 152850
• 17 Yang Q, Graham TE, Mody N et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005; 436: 356-362
• 18 Iglesias P, Díez JJ. Influence of thyroid dysfunction on serum concentrations of adipocytokines. Cytokine 2007; 40: 61-70
• 19 Diez JJ, Iglesias P. Hot Thyroidology. 2009 HT18/09
• 20 Pontikides N, Krassas GE. Basic endocrine products of adipose tissue in states of thyroid dysfunction. Thyroid 2007; 17: 421-431
• 21 Iglesias P, Alvarez Fidalgo P, Codoceo R et al. Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clin Endocrinol (Oxf) 2003; 59: 621-629
• 22 Santini F, Marsili A, Mammoli C et al. Serum concentrations of adiponectin and leptin in patients with thyroid dysfunctions. J Endocrinol Invest 2004; 27: RC5-RC7
• 23 Yaturu S, Prado S, Grimes SR. Changes in adipocyte hormones leptin, resistin, and adiponectin in thyroid dysfunction. J Cell Biochem 2004; 93: 491-496
• 24 Sieminska L, Niedziolka D, Pillich A et al. Serum concentrations of adiponectin and resistin in hyperthyroid Graves’ disease patients. J Endocrinol Invest 2008; 31: 745-749
• 25 Chu CH, Lam HC, Lee JK et al. Hyperthyroidism-associated insulin resistance is not mediated by adiponectin levels. J Thyroid Res 2011; 2011: 194721
• 26 Altinova AE, Toruner FB, Akturk M et al. Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism. Clin Endocrinol (Oxf) 2006; 65: 530-535
• 27 Morissette MR, Stricker JC, Rosenberg MA et al. Effects of myostatin deletion in aging mice. Aging Cell 2009; 5: 573-583
• 28 Solini A, Dardano A, Santini E et al. Adipocytokines mark insulin sensitivity in euthyroid Hashimoto’s patients. Acta Diabetol 2013; 50: 73-80
• 29 Aso Y, Yamamoto R, Wakabayashi S et al. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes 2006; 55: 1954-1960